DK0596891T3 - Aminoalkylsubstituerede 2-amino-5-mercaptothiadiazoler, deres fremstilling og anvendelse - Google Patents

Aminoalkylsubstituerede 2-amino-5-mercaptothiadiazoler, deres fremstilling og anvendelse

Info

Publication number
DK0596891T3
DK0596891T3 DK92910040T DK92910040T DK0596891T3 DK 0596891 T3 DK0596891 T3 DK 0596891T3 DK 92910040 T DK92910040 T DK 92910040T DK 92910040 T DK92910040 T DK 92910040T DK 0596891 T3 DK0596891 T3 DK 0596891T3
Authority
DK
Denmark
Prior art keywords
pct
aminoalkyl
amino
substituted
preparation
Prior art date
Application number
DK92910040T
Other languages
Danish (da)
English (en)
Inventor
Beatrice Rendenbach-Mueller
Hans-Juergen Teschendorf
Liliane Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0596891T3 publication Critical patent/DK0596891T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK92910040T 1991-06-15 1992-05-08 Aminoalkylsubstituerede 2-amino-5-mercaptothiadiazoler, deres fremstilling og anvendelse DK0596891T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4119758A DE4119758A1 (de) 1991-06-15 1991-06-15 Aminoalkylsubstituierte 2-amino-5-mercaptothiadiazole, ihre herstellung und verwendung
PCT/EP1992/001003 WO1992022542A1 (fr) 1991-06-15 1992-05-08 2-amino-5-mercaptothiadiazoles a substituant aminoalkyle, leur fabrication et leur utilisation

Publications (1)

Publication Number Publication Date
DK0596891T3 true DK0596891T3 (da) 1998-10-26

Family

ID=6434012

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92910040T DK0596891T3 (da) 1991-06-15 1992-05-08 Aminoalkylsubstituerede 2-amino-5-mercaptothiadiazoler, deres fremstilling og anvendelse

Country Status (9)

Country Link
US (1) US5401743A (fr)
EP (1) EP0596891B1 (fr)
JP (1) JP3199736B2 (fr)
AT (1) ATE169619T1 (fr)
CA (1) CA2111442A1 (fr)
DE (2) DE4119758A1 (fr)
DK (1) DK0596891T3 (fr)
ES (1) ES2118817T3 (fr)
WO (1) WO1992022542A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425145A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung von Thiazol- und Thiadiazolverbindungen
WO1998030561A1 (fr) * 1997-01-14 1998-07-16 EGIS Gyógyszergyár Rt. NOUVEAUX DERIVES DE 2-(1,2,4-TRIAZOLE-1-YL)-1,3,4-THIADIAZOLE EXERçANT UN EFFET SUR LE SYSTEME NERVEUX CENTRAL ET SUR LE COEUR
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
EP1272187B1 (fr) * 2000-03-27 2008-07-30 Abbott GmbH & Co. KG Ligands du recepteur d3 de la dopamine destines au traitement de la dependance
EP4092013A1 (fr) 2017-06-20 2022-11-23 Imbria Pharmaceuticals, Inc. Compositions et procédés pour augmenter l'efficacité du métabolisme cardiaque
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4074049A (en) * 1976-11-19 1978-02-14 The Dow Chemical Company Antithrombotic 1,3,4-thiadiazole
JPS62153276A (ja) * 1985-12-26 1987-07-08 Yamanouchi Pharmaceut Co Ltd 含窒素５員複素環化合物及びその製造法

Also Published As

Publication number Publication date
US5401743A (en) 1995-03-28
WO1992022542A1 (fr) 1992-12-23
EP0596891B1 (fr) 1998-08-12
JPH06507887A (ja) 1994-09-08
ATE169619T1 (de) 1998-08-15
ES2118817T3 (es) 1998-10-01
CA2111442A1 (fr) 1992-12-23
JP3199736B2 (ja) 2001-08-20
DE4119758A1 (de) 1992-12-17
EP0596891A1 (fr) 1994-05-18
DE59209455D1 (de) 1998-09-17

Similar Documents

Publication Publication Date Title
NO306346B1 (no) N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat
DK0668869T3 (da) 2-[3-(4-amidinophenyl)]-propionsyrederivater, deres fremstilling og anvendelse
BR9706986A (pt) 5-Amino-1,2,4-tiadiazóis acilados
DE59200277D1 (de) Substituierte Diaminophthalimide und Analoga.
ES2143666T3 (es) P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales.
DK0596891T3 (da) Aminoalkylsubstituerede 2-amino-5-mercaptothiadiazoler, deres fremstilling og anvendelse
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
DK0589903T3 (da) Aminoalkylsubstituerede 5-mercaptothiazoler, deres fremstilling og anvendelse
DK0589908T3 (da) Aminoalkylsubsituerede thiazolin-2-oner, deres fremstilling og deres anvendelse
FI923679A (fi) Ny b-fenylisoserinderivat, dess framstaellning och anvaendning
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
DK0592453T3 (da) Aminoalkylsubstituerede 2-amino-1,3,4-thiadiazoler, deres fremstilling og deres anvendelse
ATE92069T1 (de) 4-substituierte 10-cyanmethylenpyrrolo(4,3-e>benzo-azepine.
NO952292D0 (no) Nye triazolokinazoliner, deres fremstilling og anvendelse
ES2093280T3 (es) Derivados de leucotrieno-b 4?, procedimiento de obtencion y farmacos.
NO952291L (no) Nye triazolopyrimidoner, deres fremstilling og deres anvendelse